PLUS1
0.1941
-0.0043 (-2.17%)
-0.0043 (-2.17%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 420,453 |
|
|||||
| News | - | ||||||
| Day High | 0.2038 | Low High |
|||||
| Day Low | 0.1901 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Adamis Pharmaceuticals Corporation | ADMP | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0043 | -2.17% | 0.1941 | 11:28:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1983 | 0.1901 | 0.2038 | 0.196 | 0.1984 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 529 | 420,453 | US$ 0.195013 | US$ 81,994 | - | 0.12 - 0.734499 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:53:13 | 20 | US$ 0.2009 | USD |
Period:
Draw Mode:
Adamis Pharmaceuticals Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 29.11M | 149.98M | 149.41M | US$ 7.72M | US$ - | -0.32 | -0.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 5.70% |
Adamis Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 15/11/2022 | 08:59 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 15/11/2022 | 08:48 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 15/11/2022 | 08:10 | GlobeNewswire Inc. | Adamis Pharmaceuticals Reports Third Quarter 2022 Financial.. |
| 08/11/2022 | 08:05 | GlobeNewswire Inc. | Adamis Pharmaceuticals Schedules Third Quarter 2022.. |
| 04/10/2022 | 21:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 04/10/2022 | 21:09 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 04/10/2022 | 07:30 | GlobeNewswire Inc. | Adamis Announces Review of Strategic Alternatives |
| 24/9/2022 | 07:08 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 24/9/2022 | 07:06 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) |
| 21/9/2022 | 21:30 | GlobeNewswire Inc. | Adamis Provides Update on the Phase 2/3 Trial of Tempol in.. |
| 20/9/2022 | 20:03 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 13/9/2022 | 06:05 | GlobeNewswire Inc. | Adamis Provides an Enrollment Update on the Phase 2/3 Study.. |
Historical ADMP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.20 | 0.2098 | 0.185 | 0.1957151 | 486,291 | -0.0059 | -2.95% |
| 1 Month | 0.1433 | 0.23 | 0.1413 | 0.1922354 | 574,686 | 0.0508 | 35.45% |
| 3 Months | 0.1321 | 0.233 | 0.13 | 0.1803936 | 625,032 | 0.062 | 46.93% |
| 6 Months | 0.3746 | 0.40 | 0.12 | 0.1977402 | 1,208,814 | -0.1805 | -48.18% |
| 1 Year | 0.6226 | 0.734499 | 0.12 | 0.3201021 | 983,124 | -0.4285 | -68.82% |
| 3 Years | 0.69 | 2.34 | 0.12 | 1.02 | 4,566,489 | -0.4959 | -71.87% |
| 5 Years | 4.05 | 5.10 | 0.12 | 1.14 | 3,060,503 | -3.86 | -95.21% |